Cleared Traditional

K230214 - Huma RPM (RPM)

K230214 is an FDA 510(k) clearance for Huma RPM (RPM), manufactured by Medopad, Inc.. The device is a Class 2 Cardiovascular device with product code MWI cleared through the Traditional 510(k) pathway after a 127-day FDA review.

K230214 · Medopad, Inc. · Cardiovascular device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Jun 2023
Decision
127d
Days
Class 2
Risk

K230214 is an FDA 510(k) clearance for the Huma RPM (RPM). Classified as Monitor, Physiological, Patient (without Arrhythmia Detection Or Alarms) (product code MWI), Class II - Special Controls.

Submitted by Medopad, Inc. (New York, US). The FDA issued a Cleared decision on June 2, 2023 after a review of 127 days - within the typical 510(k) review window.

This device falls under the Cardiovascular FDA review panel, regulated under 21 CFR 870.2300 - the FDA cardiovascular device oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Cardiovascular review framework, consistent with the majority of Class II 510(k) submissions.

View all Medopad, Inc. devices

FDA 510(k) Submission Details - K230214

510(k) Number K230214 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received January 26, 2023
Decision Date June 02, 2023
Days to Decision 127 days
Submission Type Traditional
Review Panel Cardiovascular (CV)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
2d slower than avg
Panel avg: 125d · This submission: 127d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

MWI Device Classification - Class 2, Special Controls

Product Code MWI Monitor, Physiological, Patient (without Arrhythmia Detection Or Alarms)
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 870.2300
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Cardiovascular devices follow this clearance model.

Regulatory Peers - MWI Monitor, Physiological, Patient (without Arrhythmia Detection Or Alarms)

All 153
Devices cleared under the same product code (MWI) and FDA review panel - the closest regulatory comparables to K230214.
Change Healthcare Cardiology Hemodynamics™
K230881 · Change Healthcare Israel , Ltd. · Sep 2023
Portrait™ Central Viewer Application (Portrait CV A01), Portrait ™ Core Services (Portrait CSS01), Portrait™ Clinical Alarming Unit (Portrait CAU01)
K230626 · Ge Medical Systems Information Technologies, Inc. · Aug 2023
ARC Intensive Care Information System (ARC System)
K220117 · Ordinatrum Solutions · Jun 2023
The Heart Seat
K222330 · Casana Care, Inc. · Apr 2023
Radical-7 Pulse CO-Oximeter and Accessories, Rad-97 and Accessories
K212161 · Masimo Corporation · Mar 2023
VS 8 Vital Signs Monitor, VS 8A Vital Signs Monitor, VS 9 Vital Signs Monitor
K221267 · Shenzhen Mindray Bio-Meidcal Electronics Co., Ltd. · Dec 2022